Oricell Therapeutics completes USD110m pre-IPO financing

Tempus expands oncology collaboration with Gilead to accelerate AI-driven R&D

Coiled Therapeutics reports enhanced efficacy for AO-252 and accelerates transition to dose expansion

IDEOlogy Health and West Cancer Center partner to advance patient-centred oncology education and care

Gilead to acquire Tubulis to expand ADC oncology capabilities

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management

GSK's bepirovirsen accepted for review in China as potential Hepatitis B functional cure

Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences

GXO appointed to manage NHS England bowel cancer home testing kits